|
OMIM |
Link |
Information gain |
01 |
|
WM1
|
[NCBI]
|
0.0117976
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
0.00649483
|
|
|
SLE
|
[NCBI]
|
0.00585808
|
|
|
IGAD1
|
[NCBI]
|
0.00564179
|
|
|
IGAN1
|
[NCBI]
|
0.0039555
|
|
|
RA
|
[NCBI]
|
0.00386119
|
|
|
cryoglobulinemia, familial mixed
|
[NCBI]
|
0.00266455
|
|
|
HIGM1
|
[NCBI]
|
0.00198221
|
|
|
MAG
|
[NCBI]
|
0.00172711
|
|
|
CF
|
[NCBI]
|
0.000848823
|
|
|
CVID
|
[NCBI]
|
0.000838305
|
|
|
AD
|
[NCBI]
|
0.000622494
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
0.000547683
|
|
|
immunodeficiency with hyper-igm, type 2
|
[NCBI]
|
0.000456354
|
|
|
CD40LG
|
[NCBI]
|
0.000393403
|
|
|
MBP
|
[NCBI]
|
0.000260819
|
|
|
BCGF
|
[NCBI]
|
0.000255514
|
|
|
myeloma, multiple
|
[NCBI]
|
0.000214189
|
|
|
AICDA
|
[NCBI]
|
0.000181362
|
|
|
FA
|
[NCBI]
|
0.000134044
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
9.71306e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
9.4704e-05
|
|
|
gamma-a-globulin, defect in assembly of
|
[NCBI]
|
9.12321e-05
|
|
|
immunodeficiency with hyper-igm, type 4
|
[NCBI]
|
9.12321e-05
|
|
|
ataxia-telangiectasia with generalized skin pigmentation and early death
|
[NCBI]
|
9.12321e-05
|
|
|
immune deficiency, familial variable
|
[NCBI]
|
9.12321e-05
|
|
|
glomerulonephritis with sparse hair and telangiectases
|
[NCBI]
|
9.12321e-05
|
|
|
immunodeficiency with hyper-igm, type 5
|
[NCBI]
|
9.12321e-05
|
|
|
lymphoid system deterioration, progressive
|
[NCBI]
|
9.12321e-05
|
|
|
immunodeficiency due to defect in mapbp-interacting protein
|
[NCBI]
|
9.12321e-05
|
|
|
diarrhea, glucose-stimulated secretory, with common variable immunodeficiency
|
[NCBI]
|
9.12321e-05
|
|
|
rheumatoid factor igm idiotypes
|
[NCBI]
|
9.12321e-05
|
|
|
CD40
|
[NCBI]
|
8.48397e-05
|
|
|
heart block, congenital
|
[NCBI]
|
8.24824e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
7.64905e-05
|
|
|
TNF
|
[NCBI]
|
7.63971e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
7.56922e-05
|
|
|
BTK
|
[NCBI]
|
7.08849e-05
|
|
|
TNFRSF13C
|
[NCBI]
|
7.0135e-05
|
|
|
fc fragment of iga and igm, receptor for
|
[NCBI]
|
6.85108e-05
|
|
|
FTD
|
[NCBI]
|
6.84249e-05
|
|
|
VEGF
|
[NCBI]
|
6.10311e-05
|
|
|
dermographism, familial
|
[NCBI]
|
6.00606e-05
|
|
|
persistent polyclonal b-cell lymphocytosis
|
[NCBI]
|
6.00606e-05
|
|
|
wiskott-aldrich syndrome
|
[NCBI]
|
6.00606e-05
|
|
|
CSTF2
|
[NCBI]
|
5.82943e-05
|
|
|
TNFRSF13B
|
[NCBI]
|
5.76637e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
5.37092e-05
|
|
|
ALB
|
[NCBI]
|
4.92504e-05
|
|
|
secretory component deficiency
|
[NCBI]
|
4.85563e-05
|
|
|
erythroleukemia, familial
|
[NCBI]
|
4.85563e-05
|
|
|
hypoproteinemia, hypercatabolic
|
[NCBI]
|
4.85563e-05
|
|
|
caffey disease
|
[NCBI]
|
4.85563e-05
|
|
|
icos deficiency
|
[NCBI]
|
4.85563e-05
|
|
|
immunodeficiency without anhidrotic ectodermal dysplasia
|
[NCBI]
|
4.85563e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
4.85563e-05
|
|
|
IKBKG
|
[NCBI]
|
4.7782e-05
|
|
|
EGF
|
[NCBI]
|
4.73089e-05
|
|
|
LYN
|
[NCBI]
|
4.61295e-05
|
|
|
XLP1
|
[NCBI]
|
4.39171e-05
|
|
|
TLR9
|
[NCBI]
|
4.26926e-05
|
|
|
CD19
|
[NCBI]
|
4.17859e-05
|
|
|
IGAD2
|
[NCBI]
|
4.12325e-05
|
|
|
vitiligo
|
[NCBI]
|
4.12325e-05
|
|
|
UNG
|
[NCBI]
|
4.03281e-05
|
|
|
ICOS
|
[NCBI]
|
3.78717e-05
|
|
|
FSGS1
|
[NCBI]
|
3.58942e-05
|
|
|
BL
|
[NCBI]
|
3.41916e-05
|
|
|
CHH
|
[NCBI]
|
3.38635e-05
|
|
|
AFP
|
[NCBI]
|
3.31204e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.28229e-05
|
|
|
PAX5
|
[NCBI]
|
3.28003e-05
|
|
|
ragweed sensitivity
|
[NCBI]
|
3.17253e-05
|
|
|
FMF
|
[NCBI]
|
3.06756e-05
|
|
|
NGFB
|
[NCBI]
|
2.85508e-05
|
|
|
IGKC
|
[NCBI]
|
2.80642e-05
|
|
|
mapbp-interacting protein
|
[NCBI]
|
2.68349e-05
|
|
|
ARHGEF1
|
[NCBI]
|
2.68349e-05
|
|
|
POLQ
|
[NCBI]
|
2.68349e-05
|
|
|
CLL
|
[NCBI]
|
2.67795e-05
|
|
|
GTS
|
[NCBI]
|
2.65643e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
2.55609e-05
|
|
|
mulibrey nanism
|
[NCBI]
|
2.54822e-05
|
|
|
PTH
|
[NCBI]
|
2.53394e-05
|
|
|
TRAF2
|
[NCBI]
|
2.53178e-05
|
|
|
CD79A
|
[NCBI]
|
2.40418e-05
|
|
|
HCLS1
|
[NCBI]
|
2.40418e-05
|
|
|
CLCF1
|
[NCBI]
|
2.40418e-05
|
|
|
IGJ
|
[NCBI]
|
2.40418e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.2871e-05
|
|
|
TG
|
[NCBI]
|
2.26501e-05
|
|
|
BACH2
|
[NCBI]
|
2.22312e-05
|
|
|
NUCB1
|
[NCBI]
|
2.22312e-05
|
|
|
SH2D2A
|
[NCBI]
|
2.22312e-05
|
|
|
KIF23
|
[NCBI]
|
2.22312e-05
|
|
|
APCS
|
[NCBI]
|
2.15676e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.12243e-05
|
|
|
WAS
|
[NCBI]
|
2.10122e-05
|
|
|
IL2
|
[NCBI]
|
2.09518e-05
|
|
|
TNFRSF17
|
[NCBI]
|
2.08871e-05
|
|
|
POU2F2
|
[NCBI]
|
2.08871e-05
|
|
|
CD79B
|
[NCBI]
|
2.08871e-05
|
|
|
JAK3
|
[NCBI]
|
2.00551e-05
|
|
|
GGTA1
|
[NCBI]
|
1.98178e-05
|
|
|
IGHD
|
[NCBI]
|
1.98178e-05
|
|
|
switch-associated protein 70
|
[NCBI]
|
1.98178e-05
|
|
|
PRKCB1
|
[NCBI]
|
1.893e-05
|
|
|
IL21
|
[NCBI]
|
1.893e-05
|
|
|
CD22
|
[NCBI]
|
1.893e-05
|
|
|
CRH
|
[NCBI]
|
1.78097e-05
|
|
|
POU2AF1
|
[NCBI]
|
1.75092e-05
|
|
|
BLR1
|
[NCBI]
|
1.75092e-05
|
|
|
RCV1
|
[NCBI]
|
1.69219e-05
|
|
|
IGHM
|
[NCBI]
|
1.63944e-05
|
|
|
IGHMBP2
|
[NCBI]
|
1.63944e-05
|
|
|
CR2
|
[NCBI]
|
1.63944e-05
|
|
|
MIRN155
|
[NCBI]
|
1.63944e-05
|
|
|
EGFR
|
[NCBI]
|
1.61121e-05
|
|
|
NPS
|
[NCBI]
|
1.60264e-05
|
|
|
IL4
|
[NCBI]
|
1.59436e-05
|
|
|
TNFSF6
|
[NCBI]
|
1.56742e-05
|
|
|
PRL
|
[NCBI]
|
1.56182e-05
|
|
|
XBP1
|
[NCBI]
|
1.5478e-05
|
|
|
TCL1A
|
[NCBI]
|
1.5478e-05
|
|
|
BLNK
|
[NCBI]
|
1.5478e-05
|
|
|
CALR
|
[NCBI]
|
1.5478e-05
|
|
|
PIGR
|
[NCBI]
|
1.52563e-05
|
|
|
ACHE
|
[NCBI]
|
1.51889e-05
|
|
|
OLR1
|
[NCBI]
|
1.50746e-05
|
|
|
ICOSLG
|
[NCBI]
|
1.50746e-05
|
|
|
CBP2
|
[NCBI]
|
1.47007e-05
|
|
|
CHS
|
[NCBI]
|
1.43022e-05
|
|
|
BLM
|
[NCBI]
|
1.40659e-05
|
|
|
TXN
|
[NCBI]
|
1.40264e-05
|
|
|
CD14
|
[NCBI]
|
1.37202e-05
|
|
|
IL7
|
[NCBI]
|
1.37202e-05
|
|
|
THY1
|
[NCBI]
|
1.34315e-05
|
|
|
TGM2
|
[NCBI]
|
1.31584e-05
|
|
|
SN
|
[NCBI]
|
1.26534e-05
|
|
|
WIPF1
|
[NCBI]
|
1.26534e-05
|
|
|
ARNTL
|
[NCBI]
|
1.24188e-05
|
|
|
CR1
|
[NCBI]
|
1.24188e-05
|
|
|
CD
|
[NCBI]
|
1.2311e-05
|
|
|
RNASE3
|
[NCBI]
|
1.21926e-05
|
|
|
ADA
|
[NCBI]
|
1.19121e-05
|
|
|
ANXA5
|
[NCBI]
|
1.17753e-05
|
|
|
CD44
|
[NCBI]
|
1.10306e-05
|
|
|
TNFSF8
|
[NCBI]
|
1.06972e-05
|
|
|
GJA5
|
[NCBI]
|
1.06972e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
1.03567e-05
|
|
|
DNMT3B
|
[NCBI]
|
1.02368e-05
|
|
|
APOH
|
[NCBI]
|
1.00927e-05
|
|
|
IL18
|
[NCBI]
|
1.00927e-05
|
|
|
IL5
|
[NCBI]
|
9.55668e-06
|
|
|
AGTR1
|
[NCBI]
|
9.43173e-06
|
|
|
TNFSF13B
|
[NCBI]
|
9.43173e-06
|
|
|
PTPRC
|
[NCBI]
|
9.31004e-06
|
|
|
PLTP
|
[NCBI]
|
9.29368e-06
|
|
|
RP
|
[NCBI]
|
9.26159e-06
|
|
|
VIP
|
[NCBI]
|
8.95223e-06
|
|
|
TNFRSF6
|
[NCBI]
|
8.853e-06
|
|
|
WAS
|
[NCBI]
|
8.53786e-06
|
|
|
C4A
|
[NCBI]
|
8.4375e-06
|
|
|
SH2D1A
|
[NCBI]
|
7.96686e-06
|
|
|
PROCR
|
[NCBI]
|
7.70672e-06
|
|
|
KIT
|
[NCBI]
|
7.70672e-06
|
|
|
TFRC
|
[NCBI]
|
7.70672e-06
|
|
|
CAT
|
[NCBI]
|
7.68191e-06
|
|
|
UMOD
|
[NCBI]
|
7.54149e-06
|
|
|
BCL2
|
[NCBI]
|
7.46117e-06
|
|
|
LIP
|
[NCBI]
|
7.34356e-06
|
|
|
DSG3
|
[NCBI]
|
6.93741e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
6.72711e-06
|
|
|
PENK
|
[NCBI]
|
6.4091e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
6.17113e-06
|
|
|
B2M
|
[NCBI]
|
6.16838e-06
|
|
|
temporal arteritis
|
[NCBI]
|
5.83007e-06
|
|
|
EV
|
[NCBI]
|
5.60653e-06
|
|
|
HRG
|
[NCBI]
|
5.37683e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
5.28255e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
5.1337e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
5.1337e-06
|
|
|
PAEP
|
[NCBI]
|
4.92754e-06
|
|
|
CPB2
|
[NCBI]
|
4.64289e-06
|
|
|
FBN1
|
[NCBI]
|
4.45266e-06
|
|
|
MPO
|
[NCBI]
|
4.04856e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
3.93302e-06
|
|
|
LKS
|
[NCBI]
|
3.85808e-06
|
|
|
SCIDX1
|
[NCBI]
|
3.85808e-06
|
|
|
MS
|
[NCBI]
|
3.5656e-06
|
|
|
IFNA1
|
[NCBI]
|
3.46625e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.39861e-06
|
|
|
LPO
|
[NCBI]
|
3.38524e-06
|
|
|
EIG
|
[NCBI]
|
3.23448e-06
|
|
|
NGFR
|
[NCBI]
|
2.98721e-06
|
|
|
AGER
|
[NCBI]
|
2.78575e-06
|
|
|
IL6
|
[NCBI]
|
2.57838e-06
|
|
|
MCP
|
[NCBI]
|
2.51928e-06
|
|
|
PMP22
|
[NCBI]
|
2.38659e-06
|
|
|
BCR
|
[NCBI]
|
2.26078e-06
|
|
|
PF4
|
[NCBI]
|
2.23336e-06
|
|
|
EPO
|
[NCBI]
|
1.91409e-06
|
|
|
GFAP
|
[NCBI]
|
1.89644e-06
|
|
|
SOD2
|
[NCBI]
|
1.82819e-06
|
|
|
KLK3
|
[NCBI]
|
1.57983e-06
|
|
|
COMP
|
[NCBI]
|
1.51384e-06
|
|
|
TLR2
|
[NCBI]
|
1.35115e-06
|
|
|
MG
|
[NCBI]
|
1.31748e-06
|
|
|
aHUS
|
[NCBI]
|
1.20202e-06
|
|
|
GNRH1
|
[NCBI]
|
1.07982e-06
|
|
|
F3
|
[NCBI]
|
1.02267e-06
|
|
|
AMH
|
[NCBI]
|
9.96915e-07
|
|
|
TNFSF10
|
[NCBI]
|
9.54124e-07
|
|
|
APOB
|
[NCBI]
|
9.30567e-07
|
|
|
SPP1
|
[NCBI]
|
8.82531e-07
|
|
|
PI
|
[NCBI]
|
8.72721e-07
|
|
|
PCNA
|
[NCBI]
|
7.55509e-07
|
|
|
MBL2
|
[NCBI]
|
6.33643e-07
|
|
|
porphyria variegata
|
[NCBI]
|
5.85032e-07
|
|
|
GJA1
|
[NCBI]
|
5.5598e-07
|
|
|
GAPDH
|
[NCBI]
|
5.29459e-07
|
|
|
STAT3
|
[NCBI]
|
4.85101e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
4.4978e-07
|
|
|
XDH
|
[NCBI]
|
4.07696e-07
|
|
|
TF
|
[NCBI]
|
3.03922e-07
|
|
|
AHR
|
[NCBI]
|
2.27191e-07
|
|
|
JMML
|
[NCBI]
|
1.86325e-07
|
|
|
OCP
|
[NCBI]
|
1.86325e-07
|
|
|
TFPI
|
[NCBI]
|
5.21503e-08
|
|
|
PTK2
|
[NCBI]
|
2.17022e-08
|
|
|
HP
|
[NCBI]
|
2.12746e-08
|
|
|
ACP5
|
[NCBI]
|
7.10158e-09
|
|
|
AT
|
[NCBI]
|
4.15491e-09
|
|